131 related articles for article (PubMed ID: 10170319)
21. Practical considerations for conducting effective billing audits.
Bacon RF
Healthc Financ Manage; 2002 Apr; 56(4):36-9. PubMed ID: 11963596
[TBL] [Abstract][Full Text] [Related]
22. Publication of the OIG compliance program guidance for hospitals--OIG. Notice.
Fed Regist; 1998 Feb; 63(35):8987-98. PubMed ID: 10177742
[TBL] [Abstract][Full Text] [Related]
23. Will your compliance plan pass the effectiveness test?
Fogel LA
Healthc Financ Manage; 2000 Apr; 54(4):54-7. PubMed ID: 10915352
[TBL] [Abstract][Full Text] [Related]
24. AMA urges physician office compliance plans: what should you do now?
Schwartz JB; Snider JG
Health Care Law Mon; 1998 Nov; ():12-5. PubMed ID: 10346225
[No Abstract] [Full Text] [Related]
25. The paper monster. Corporate compliance and the board.
Hinrichsen CA; Capobianco C; Diamond M
Trustee; 2001 Feb; 54(2):12-6, 1. PubMed ID: 11262926
[TBL] [Abstract][Full Text] [Related]
26. Tailoring a corporate compliance program for an IDS.
Berkey MF
Healthc Financ Manage; 1999 Jan; 53(1):50-3. PubMed ID: 10339165
[TBL] [Abstract][Full Text] [Related]
27. An audit a day keeps the agency at bay: OIG's evolving view of hospital compliance programs (part 2).
Siegel S
Health Care Law Mon; 2004 Sep; ():3-9. PubMed ID: 15484833
[No Abstract] [Full Text] [Related]
28. Process improvement program evolves into compliance program at an integrated delivery system.
Tyk RC; Hylton PG
Healthc Financ Manage; 1998 Sep; 52(9):60-2. PubMed ID: 10182746
[TBL] [Abstract][Full Text] [Related]
29. Complex regulations are driving hospitals' corporate compliance efforts.
Campbell S
Health Care Strateg Manage; 1998 Apr; 16(4):17. PubMed ID: 10178054
[No Abstract] [Full Text] [Related]
30. Corporate compliance programs for FDA-regulated companies: incentives for their development and the impact of the federal sentencing guidelines for organizations.
Freyer DH
Food Drug Law J; 1996; 51(2):225-42. PubMed ID: 11820200
[No Abstract] [Full Text] [Related]
31. Preventing fraud and abuse fallout.
Mayer CM
Healthc Financ Manage; 1995 Apr; 49(4):40, 42, 44 passim. PubMed ID: 10146166
[TBL] [Abstract][Full Text] [Related]
32. OIG issues guidance to hospitals seeking to reduce fraud and abuse risks.
Hirsch WR
J Oncol Manag; 1998; 7(3):14-5. PubMed ID: 10181575
[No Abstract] [Full Text] [Related]
33. Internal investigations: a proactive approach to compliance.
Schillaci A; Radler L
Healthc Financ Manage; 2000 Sep; 54(9):58-60. PubMed ID: 11066390
[TBL] [Abstract][Full Text] [Related]
34. DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics and Supply) model compliance program: does the OIG have it right?
Parver C; O'Connor B
Caring; 1999 Jun; 18(6):20-3. PubMed ID: 10538888
[TBL] [Abstract][Full Text] [Related]
35. Model compliance plan due soon from HHS; consortium readies itself.
Hosp Peer Rev; 1997 Nov; 22(11):157-8. PubMed ID: 10173983
[No Abstract] [Full Text] [Related]
36. A team approach to fraud prevention.
Luizzo A
J Healthc Prot Manage; 1993; 9(2):76-80. PubMed ID: 10129067
[TBL] [Abstract][Full Text] [Related]
37. Corporate compliance is not enough. Catholic healthcare organizations should aim at the development of ethical cultures.
Giblin MJ; Meaney ME
Health Prog; 1998; 79(5):30-1. PubMed ID: 10187516
[No Abstract] [Full Text] [Related]
38. Corporate compliance plans: building the bridge to a well-managed future.
Bruder P
Hosp Top; 1998; 76(1):32-4. PubMed ID: 10181331
[No Abstract] [Full Text] [Related]
39. Making the best of corporate integrity agreements.
Henderson WM; Imperato GL
Healthc Financ Manage; 2001 Jul; 55(7):58-60. PubMed ID: 11467232
[TBL] [Abstract][Full Text] [Related]
40. Roundtable takes on compliance challenges.
Prophet S
J AHIMA; 1999; 70(7):20-6. PubMed ID: 10538806
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
